• 2019
  Verdonk F, Petit AC, Abdel-Ahad P, Vinckier F, Jouvion G, de Maricourt P, De Medeiros GF, Danckaert A, Van Steenwinckel J, Blatzer M, Maignan A, Langeron O, Sharshar T, Callebert J, Launay JM, Chrétien F, Gaillard R., Microglial production of quinolinic acid as a target and a biomarker of the antidepressant effect of ketamine., Brain Behav Immun. 2019 Jun 28.
• 2015
  Montejo AL, Deakin J, Gaillard R, Harmer C, Meyniel F, Jabourian A, Gabriel C, Gruget C, Klinge C, MacFayden C, Milligan H, Mullings E, Goodwin G, Better sexual acceptability of agomelatine (25 and 50 mg) compared to escitalopram (20 mg) in healthy volunteers. A 9-week, placebo-controlled study using the PRSexDQ scale, J. Psychopharmacol. (Oxford) 2015 Aug;.
• 2015
  Costemale-Lacoste J, Gaillard R, Corruble E, Mouaffak F, Is Polyuria a Predictive Sign of Lithium Response in Major Depression?, J Clin Psychopharmacol 2015 Aug;35(4):471-2.
• 2015
  Vinckier F, Gaillard R, Palminteri S, Rigoux L, Salvador A, Fornito A, Adapa R, Krebs MO, Pessiglione M, Fletcher PC, Confidence and psychosis: a neuro-computational account of contingency learning disruption by NMDA blockade, Mol. Psychiatry 2015 Jun;.
• 2015
  Gaillard R, [The legacy of Jean Delay in psychiatry], Encephale 2015 Apr;41(2):105-7.
• 2015
  Gaillard R, Smadja S, [Acute hallucinatory psychosis], Rev Prat 2015 Feb;65(2):223-7.
• 2014
  Dandash O, Harrison BJ, Adapa R, Gaillard R, Giorlando F, Wood SJ, Fletcher PC, Fornito A, Selective augmentation of striatal functional connectivity following NMDA receptor antagonism: implications for psychosis, Neuropsychopharmacology 2015 Feb;40(3):622-31.
• 2014
  Pillet B, Morvan Y, Todd A, Franck N, Duboc C, Grosz A, Launay C, Demily C, Gaillard R, Krebs MO, Amado I, Cognitive remediation therapy (CRT) benefits more to patients with schizophrenia with low initial memory performances, Disabil Rehabil 2015;37(10):846-53.
• 2014
  Mauras T, Masson M, Ducros A, Bourgin J, Del Cul A, Fossati P, Gaillard R, Reversible cerebral vasoconstriction syndrome and treatment with monoamine oxidase inhibitor, Aust N Z J Psychiatry 2014 Jul;48(7):684-5.
• 2014
  Moura DS, Georgin-Lavialle S, Gaillard R, Hermine O, Neuropsychological features of adult mastocytosis, Immunol Allergy Clin North Am 2014 May;34(2):407-22.
• 2014
  Krebs MO, Morvan Y, Jay T, Gaillard R, Kebir O, Psychotomimetic effects at initiation of cannabis use are associated with cannabinoid receptor 1 (CNR1) variants in healthy students, Mol. Psychiatry 2014 Apr;19(4):402-3.
• 2014
  De Maricourt P, Jay T, Goncalvès P, Lôo H, Gaillard R, [Ketamine’s antidepressant effect: literature review on clinical use], Encephale 2014 Feb;40(1):15-23.
• 2014
  De Maricourt P, Jay T, Goncalvès P, Lôo H, Gaillard R, [Ketamine’s antidepressant effect: focus on ketamine mechanisms of action], Encephale 2014 Feb;40(1):48-55.
• 2013
  Magaud E, Morvan Y, Rampazzo A, Alexandre C, Willard D, Gaillard R, Kazes M, Krebs MO, Subjects at Ultra High Risk for psychosis have ‘heterogeneous’ intellectual functioning profile: a multiple-case study, Schizophr. Res. 2014 Feb;152(2-3):415-20.
• 2013
  Vinckier F, Cohen L, Oppenheim C, Salvador A, Picard H, Amado I, Krebs MO, Gaillard R, Reading impairment in schizophrenia: dysconnectivity within the visual system, Neuropsychologia 2014 Jan;53:187-96.
• 2013
  Angst J, Hantouche E, Caci H, Gaillard R, Lancrenon S, Azorin JM, DSM-IV diagnosis in depressed primary care patients with previous psychiatric ICD-10 bipolar disorder, J Affect Disord 2014 Jan;152-154:295-8.
• 2013
  Vermersch C, Smadja S, Amselem O, Gay O, Marcellin L, Gaillard R, Mignon A, [Cesarean section and sismotherapy in a severe psychotic parturient: A case report], Ann Fr Anesth Reanim 2013 Oct;32(10):711-4.
• 2013
  Gaillard R, Gourion D, Llorca PM, [Anhedonia in depression], Encephale 2013 Sep;39(4):296-305.
• 2013
  Zaki H, Sentissi O, Olié JP, Lôo H, Mouaffak F, Gaillard R, [The interest of maintenance electroconvulsive therapy in mood disorders], Encephale 2013 Oct;39(5):367-73.
• 2012
  Gaillard R, [Depression and functional cerebral imaging], Encephale 2012 Dec;38 Suppl 2:S37-40.
• 2012
  Gay O, Plaze M, Oppenheim C, Mouchet-Mages S, Gaillard R, Olié JP, Krebs MO, Cachia A, Cortex morphology in first-episode psychosis patients with neurological soft signs, Schizophr Bull 2013 Jul;39(4):820-9.
• 2012
  Moura DS, Sultan S, Georgin-Lavialle S, Barete S, Lortholary O, Gaillard R, Hermine O, Evidence for cognitive impairment in mastocytosis: prevalence, features and correlations to depression, PLoS ONE 2012;7(6):e39468.
• 2012
  Mir O, Durand JP, Boudou-Rouquette P, Giroux J, Coriat R, Cessot A, Ropert S, Goldwasser F, Gaillard R, Interaction between serotonin reuptake inhibitors, 5-HT3 antagonists, and NK1 antagonists in cancer patients receiving highly emetogenic chemotherapy: a case-control study, Support Care Cancer 2012 Sep;20(9):2235-9.
• 2012
  Picard H, Le Seac'h A, Amado I, Gaillard R, Krebs MO, Beauvillain C, Impaired saccadic adaptation in schizophrenic patients with high neurological soft sign scores, Psychiatry Res 2012 Aug;199(1):12-8.
• 2012
  Mir O, Adam J, Gaillard R, Gregory T, Veyrie N, Yordanov Y, Berveiller P, Chousterman B, Loulergue P, Vaccination coverage among medical residents in Paris, France, Clin. Microbiol. Infect. 2012 May;18(5):E137-9.
• 2011
  Ziauddeen H, Subramaniam N, Gaillard R, Burke LK, Farooqi IS, Fletcher PC, Food images engage subliminal motivation to seek food, Int J Obes (Lond) 2012 Sep;36(9):1245-7.
• 2011
  Gaillard A, Gaillard R, Mouaffak F, Radtchenko A, Lôo H, [Case report: electroconvulsive therapy in a 33-year-old man with hysterical quadriplegia], Encephale 2012 Feb;38(1):104-9.
• 2011
  Amado I, Krebs MO, Gaillard R, Olié JP, Lôo H, [Principles of cognitive remediation in schizophrenia], Bull. Acad. Natl. Med. 2011 Jun;195(6):1319-30; discussion 1330-3.
• 2011
  Gaillard R, Mir O, Fluoxetine and motor recovery after ischaemic stroke, Lancet Neurol 2011 Jun;10(6):499; author reply 500-1.
• 2011
  Mir O, Adam J, Veyrie N, Chousterman B, Gaillard R, Gregory T, Yordanov Y, Berveiller P, Loulergue P, Accidental blood exposures among medical residents in Paris, France, Clin. Microbiol. Infect. 2011 Mar;17(3):464-6.
• 2010
  Soufia M, Plaze M, Gueguen B, Demigneux G, Olié JP, Gaillard R, Behavioral disinhibition with baclofen, J Clin Psychopharmacol 2010 Dec;30(6):759-60.
• 2010
  Loulergue P, Gaillard R, Mir O, Interaction involving tadalafil and CYP3A4 inhibition by ritonavir, Scand. J. Infect. Dis. 2011 Mar;43(3):239-40.
• 2010
  Del Cul A, Gaillard R, Jardri R, Fossati P, [Hallucinations, consciousness and psychosis], Encephale 2010 Sep;36(4):348-54.
• 2010
  Gaillard R, Loo H, Olie JP, [Mental pain: is it a symptom?], Bull. Acad. Natl. Med. 2010 Mar;194(3):567-78; discussion 578-81.
• 2009
  Gaillard R, [Comparative efficacy and acceptability of new-generation antidepressants. Synthesis meta-analysis Cipriani], Encephale 2009 Oct;35(5):499-504.
• 2009
  Mouaffak F, Gaillard R, Burgess E, Zaki H, Olié JP, Krebs MO, Clozapine-induced serositis: review of its clinical features, pathophysiology and management strategies, Clin Neuropharmacol 2009 Jul-Aug;32(4):219-23.
• 2009
  Gaillard R, Dehaene S, Adam C, Clémenceau S, Hasboun D, Baulac M, Cohen L, Naccache L, Converging intracranial markers of conscious access, PLoS Biol. 2009 Mar;7(3):e61.
• 2008
  Gaillard R, [Cerebral images in bipolar disorder], Encephale 2008 Jun;34 Suppl 4:S146-9.
• 2008
  Epelbaum S, Pinel P, Gaillard R, Delmaire C, Perrin M, Dupont S, Dehaene S, Cohen L, Pure alexia as a disconnection syndrome: new diffusion imaging evidence for an old concept, Cortex 2008 Sep;44(8):962-74.
• 2007
  Gaillard R, Del Cul A, [A scientific model of consciousness: implications for neuropsychiatic diseases], Psychol Neuropsychiatr Vieil 2007 Dec;5(4):261-7.
• 2007
  Gaillard R, Cohen L, Adam C, Clemenceau S, Hasboun D, Baulac M, Willer JC, Dehaene S, Naccache L, Subliminal words durably affect neuronal activity, Neuroreport 2007 Oct;18(15):1527-31.
• 2007
  Grégory T, Gaillard R, Grenier A, , [Hopes for future practice of junior orthopedic surgeons in France: a sociological study], Rev Chir Orthop Reparatrice Appar Mot 2007 Sep;93(5):429-34.
• 2007
  Gaillard R, Hemras A, Habert MO, Baup N, Naccache L, Gallarda T, Cohen L, Olié JP, Cognitive facilitation and behavioral disinhibition with benzodiazepine: a case report, J Clin Psychiatry 2007 Aug;68(8):1305-6.
• 2007
  Gaillard R, [Emotional dimensions of schizophrenic disorders], Encephale 2007 Jun;33 Pt 3:S371-4.
• 2006
  Gaillard R, Ouanas A, Spadone C, Llorca PM, Lôo H, Baylé FJ, [Benzodiazepines and schizophrenia, a review of the literature], Encephale 2006 Nov-Dec;32(6 Pt 1):1003-10.
• 2006
  Gaillard R, Del Cul A, Naccache L, Dehaene S, [Behavioural evidence of nonconscious semantic processing for emotional words], Med Sci (Paris) 2006 Aug-Sep;22(8-9):702-4.
• 2006
  Gaillard R, Del Cul A, Naccache L, Vinckier F, Cohen L, Dehaene S, Nonconscious semantic processing of emotional words modulates conscious access, Proc. Natl. Acad. Sci. U.S.A. 2006 May;103(19):7524-9.
• 2006
  Gaillard R, Naccache L, Pinel P, Clémenceau S, Volle E, Hasboun D, Dupont S, Baulac M, Dehaene S, Adam C, Cohen L, Direct intracranial, FMRI, and lesion evidence for the causal role of left inferotemporal cortex in reading, Neuron 2006 Apr;50(2):191-204.
• 2005
  Gaillard R, Naccache L, [Amygdala recording of emotions evoked by subliminal words], Med Sci (Paris) 2005 Oct;21(10):804-5.
• 2005
  Naccache L, Gaillard R, Adam C, Hasboun D, Clémenceau S, Baulac M, Dehaene S, Cohen L, A direct intracranial record of emotions evoked by subliminal words, Proc. Natl. Acad. Sci. U.S.A. 2005 May;102(21):7713-7.
• 2005
  Henry C, Gaillard R, Volle E, Chiras J, Ferrieux S, Dehaene S, Cohen L, Brain activations during letter-by-letter reading: a follow-up study, Neuropsychologia 2005;43(14):1983-9.
• 2004
  Naccache L, Puybasset L, Gaillard R, Serve E, Willer JC, Auditory mismatch negativity is a good predictor of awakening in comatose patients: a fast and reliable procedure, Clin Neurophysiol 2005 Apr;116(4):988-9.